Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Income towards Parent Company: 2013-2024

Historic Income towards Parent Company for Wave Life Sciences (WVE) over the last 12 years, with Dec 2024 value amounting to -$97.0 million.

  • Wave Life Sciences' Income towards Parent Company rose 12.83% to -$53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$121.9 million, marking a year-over-year increase of 14.45%. This contributed to the annual value of -$97.0 million for FY2024, which is 68.67% down from last year.
  • Per Wave Life Sciences' latest filing, its Income towards Parent Company stood at -$97.0 million for FY2024, which was down 68.67% from -$57.5 million recorded in FY2023.
  • Wave Life Sciences' 5-year Income towards Parent Company high stood at -$57.5 million for FY2023, and its period low was -$161.8 million during FY2022.
  • Its 3-year average for Income towards Parent Company is -$105.4 million, with a median of -$97.0 million in 2024.
  • In the last 5 years, Wave Life Sciences' Income towards Parent Company surged by 64.46% in 2023 and then plummeted by 68.67% in 2024.
  • Over the past 5 years, Wave Life Sciences' Income towards Parent Company (Yearly) stood at -$149.9 million in 2020, then rose by 18.45% to -$122.2 million in 2021, then crashed by 32.38% to -$161.8 million in 2022, then skyrocketed by 64.46% to -$57.5 million in 2023, then crashed by 68.67% to -$97.0 million in 2024.